| Schedule of Basic and Diluted Net Loss Per Share |
The
following table sets forth the computation of basic and diluted net loss per share for the six months ended June 30, 2025 and 2026:
Schedule
of Basic and Diluted Net Loss Per Share
| | |
2025 | | |
2026 | |
| | |
For the six months ended June 30, | |
| | |
2025 | | |
2026 | |
| Numerator: | |
| | |
| |
| Net loss | |
| (25,568 | ) | |
| (44,057 | ) |
| Net loss attributable to the Company’s ordinary shareholders | |
| (25,568 | ) | |
| (44,057 | ) |
| Denominator: | |
| | | |
| | |
| Weighted average number of ordinary shares outstanding, basic (retrospectively adjusted for effect
of the Share Consolidation)* | |
| 2,348,249 | | |
| 2,372,032 | |
| Weighted average number of ordinary shares outstanding, diluted (retrospectively adjusted for effect
of the Share Consolidation)* | |
| 2,348,249 | | |
| 2,372,032 | |
| Basic net loss per share attributable to the Company’s ordinary shareholders | |
| (10.89 | ) | |
| (18.57 | ) |
| Diluted net loss per share attributable to the Company’s ordinary shareholders | |
| (10.89 | ) | |
| (18.57 | ) |
| * |
For
the six months ended June 30, 2025 and 2026, the Company had potential ordinary shares, including restricted shares and share options.
On a weighted average basis, 2,322 and 215 restricted shares, and 43,856 and 57,509 share options were excluded from the computation
of diluted net loss per ordinary share because including them would have had an anti-dilutive effect for the six months ended June
30, 2025 and 2026, respectively. |
|